Cinnamon for PCOS: Small Trials, Real Effects, and the Coumarin Warning

Does cinnamon actually lower insulin resistance in PCOS?

Five randomised trials in PCOS populations found cinnamon reduced HOMA-IR by an average of 0.84 standard deviations compared with placebo, according to a 2021 meta-analysis pooling those trials (SMD −0.84, 95% CI −1.52 to −0.16, p = .010). That is a real, statistically significant effect — and also a wide confidence interval, which tells you the trials disagreed with each other about how big the effect actually is.

The individual trials behind that number are small and short. A 2018 randomised trial of 66 women given 1.5 g of cinnamon powder daily for 12 weeks found fasting insulin and HOMA-IR both improved significantly against placebo (p = .024 and p = .014), plus a drop in LDL cholesterol. But the same trial measured testosterone and DHEA-S and found no significant difference from placebo — cinnamon moved the insulin numbers and left the androgen numbers where they started. A separate 2018 trial of 84 overweight or obese women on 1.5 g daily for 8 weeks found the same pattern: fasting glucose, insulin, HOMA-IR, total cholesterol and LDL all improved, HDL rose, and weight dropped modestly — a broader metabolic result than the 2018 trial above, over a shorter period. The earliest trial, a 2007 pilot in 15 women over 8 weeks, found the same direction of effect on insulin resistance and explicitly called for a larger trial to confirm it — which, seventeen years and several more small trials later, is still closer to true than not.

Does cinnamon improve periods, or just insulin markers?

One trial found more frequent periods on cinnamon, and it is worth reading closely because the result contradicts the insulin-resistance mechanism the other trials point to. In a 6-month randomised trial, 45 women with PCOS took 1.5 g of cinnamon or placebo daily. Only 26 completed 3 months and 17 completed the full 6 months — a dropout rate above 60% by the end, which is its own signal about how sustainable the intervention was. Among those who stayed, cycles were more frequent on cinnamon than placebo (median 0.75 vs 0.25 cycles/month, p = .0085), and cyclicity improved from baseline by 0.23 cycles/month (95% CI 0.099–0.36) in the cinnamon group only. Ovulatory progesterone levels were confirmed in a small subsample.

Here is the part that does not fit the tidy story: insulin resistance and androgen levels did not change in either group in this trial. If cinnamon’s mechanism is insulin sensitisation, and insulin resistance did not move, the trial does not actually explain why cycles improved. The authors called their own result preliminary, and that word is doing real work — a 6-month trial that lost over 60% of its participants and found a cycle-frequency effect unsupported by the metabolic data it also collected is a lead, not a conclusion.

Cassia or Ceylon: does the type of cinnamon matter?

Retail cassia cinnamon contains roughly 2,650 to 7,017 mg of coumarin per kilogram, while a Cinnamomum verum (Ceylon) sample tested in the same study was coumarin-free, according to an analysis of 60 ground cinnamon samples from 12 brands. Almost every jar of “cinnamon” on a grocery shelf — and almost every capsule in the trials above, unless labelled otherwise — is cassia (Cinnamomum cassia or the closely related Cinnamomum burmannii), not Ceylon. Coumarin is hepatotoxic at sustained intake, which is why the European Food Safety Authority set a tolerable daily intake (TDI) of 0.1 mg per kilogram of body weight per day, a threshold cited directly in an analysis of coumarin exposure from cinnamon-containing Kampo medicines.

Do the maths on the trial dose and the retail coumarin range, and the numbers land close to that line. At 1.5 g of cassia cinnamon a day — the dose used in most of the trials above — coumarin intake works out to roughly 4 to 10.5 mg/day, using the measured retail range. For a 60–70 kg adult, the TDI is about 6–7 mg/day. That means the daily dose used in these PCOS trials can sit at, or clearly above, the regulatory safety threshold, depending on which cassia product is used — and none of the PCOS trials ran longer than 6 months, so none of them can tell you what daily cassia use looks like at 2 or 5 years.

Coumarin is also the chemical namesake of the vitamin-K-antagonist anticoagulants — warfarin, acenocoumarol, phenprocoumon — prescribed for blood clotting. No trial has tested cassia cinnamon alongside one of these drugs, so this is a mechanism-based caution rather than a confirmed interaction, not a reason to assume the two are unrelated because one is a spice and the other a prescription.

The real-world picture is more reassuring than the maths alone suggests. In the Kampo medicine study above, 76% of the 129 patients studied exceeded the TDI from cinnamon bark in their prescriptions, yet the researchers found no significant difference in abnormal liver function tests between those over and under the threshold. That does not mean exceeding the TDI is risk-free — case reports of reversible liver enzyme elevation from heavy cassia use exist, and the TDI is deliberately conservative — but it is a reason not to panic over occasional cassia in food. It is also not a reason to treat daily 1.5 g cassia supplementation as automatically safe. If you intend to take cinnamon daily for months, Ceylon removes this entire question; cassia does not.

What dose did the trials use, and how long before it works?

Every PCOS trial that found a metabolic effect used 1.5 g of cinnamon a day, split into two or three doses, for 8 to 12 weeks before measuring insulin resistance. That is the number to compare any product label against — a 500 mg capsule taken once daily is a third of the trial dose, and a “cinnamon extract” standardised for a different marker entirely is not the same product as the powder used in these trials. None of the trials tested doses below 1.5 g/day, so there is no evidence for a lower “maintenance” dose working the same way.

Insulin markers moved within 8 weeks in the two shorter trials and stayed improved at 12 weeks in the longer one. The menstrual-cyclicity signal took the full 6 months to appear and never showed up in the shorter trials — reasonable, since a cycle-frequency change cannot be measured faster than cycles occur, but it also means anyone trying cinnamon for cycle regularity specifically should not expect a result inside two months.

Who cinnamon will not help

Cinnamon has never been tested against androgen symptoms and, in the one trial that measured testosterone and DHEA-S, did not move either. If hirsutism, acne, or scalp hair thinning is your main concern, cinnamon’s evidence base gives you no reason to expect a change — that is a different mechanism, and the wider supplements ranking is a better starting point for androgen-focused options. Nobody with liver disease has been included in these trials, and the coumarin question above is precisely why cassia cinnamon is not the default recommendation for someone with impaired liver function. And if your insulin resistance is already being treated with metformin or berberine, which have far larger trial bases behind them, cinnamon’s modest additional effect has not been tested in combination with either — there is no evidence for or against stacking it on top of a prescription insulin-sensitiser like metformin.

You may see PCOS referred to as polyendocrine metabolic ovarian syndrome (PMOS) after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the cinnamon evidence above changes with the name — this article uses PCOS because that is still what people search.

Cinnamon is not the only supplement worth checking against what else you take. Supplements to avoid with PCOS covers the interactions that come up most often with hormonal contraception, spironolactone, and thyroid medication.

Common questions

Not sure whether insulin resistance is actually driving your PCOS pattern? Take the quiz before adding cinnamon or anything else — it changes which levers are worth pulling first.